2013 annual financial data
Neuphoria Therapeutics 2013 Operating cash flow margin
Direct answer
Operating cash flow margin was -418.04%.
Operating income was -18.27M USD and net income was -9.13M USD.
Operating cash flow was -10.44M USD.
Get free Neuphoria Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2.5M USD
- Operating income
- -18.27M USD
- Net income
- -9.13M USD
- Operating cash flow
- -10.44M USD